Rapport Therapeutics Inc.... (RAPP)
9.06
1.91 (26.71%)
At close: Mar 04, 2025, 1:16 PM
Rapport Therapeutics Common Stock Revenue
Rapport Therapeutics Common Stock reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending September 30, 2024, Rapport Therapeutics Common Stock generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
58
Market Cap
331.38M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |